Cross-sectional evaluation of the relationship between Vitamin D status and supplement use across levels of kidney function in adults

Linda W. Moore, Wadi N. Suki, Keri E. Lunsford, Omaima M. Sabek, Richard J. Knight, A. Osama Gaber

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

Objectives The objective of this study was to assess vitamin D status of US non-pregnant adults using a standardised assay across 15 mL/min/1.73 m 2 increments of kidney function, report the use of dietary supplements containing vitamin D and assess relationships between vitamin D and markers of bone resorption. Design This study is a cross-sectional evaluation. Setting The study is from the US National Health and Nutrition Evaluation Survey in 2001-2012. Participants The participants were non-institutionalised, non-pregnant adults, age ≥20 years. Primary and secondary outcome measures The primary outcome measure was serum 25OHD evaluated using liquid chromatography-tandem mass spectroscopy traceable to international reference standards. Secondary outcome measures were use of dietary supplements containing vitamin D and the serum intact parathyroid hormone and bone-specific alkaline phosphatase in a subset of participants. Results The median 25OHD concentration in 27 543 US non-pregnant adults was 25.7 ng/mL (range, 2.2-150.0 ng/mL). Vitamin D supplements were used by 38.0%; mean (SE)=757 (43) international units/day. The range of 25OHD concentration across groups, stratified by kidney function, was 23.0-28.1 ng/mL. The lowest concentration of 25OHD observed was in people with higher kidney function (23.0 ng/mL for estimated glomerular filtration rate >105 mL/min/1.73 m 2). Only 24% of people not taking a dietary supplement had a 25OHD concentration >30 ng/mL. Serum intact parathyroid hormone inversely correlated with 25OHD within all kidney function groups. Bone-specific alkaline phosphatase was also negatively associated with 25OHD concentration. Conclusions These data indicate that 25OHD concentrations and supplement use may be suboptimal in a significant proportion of the population, across all kidney function levels. The response of bone resorption markers further suggests that 25OHD levels could be improved. Together, these data support a re-evaluation of the 25OHD concentration associated with health in adults.

Original languageEnglish (US)
Article numbere022471
Pages (from-to)e022471
JournalBMJ open
Volume9
Issue number2
DOIs
StatePublished - Feb 22 2019

Keywords

  • 25-hydroxyvitamin D
  • Calcifediol
  • Dietary Supplements
  • Kidney Insufficiencies
  • Parathyroid Hormone
  • Vitamin D Deficiency/diagnosis

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'Cross-sectional evaluation of the relationship between Vitamin D status and supplement use across levels of kidney function in adults'. Together they form a unique fingerprint.

Cite this